John Oyler

Chief Executive Officer

John Oyler (Chief Executive Officer) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in BeOne Medicines AG (ONC). The largest single filing was $89.3M of ONC (282,921 sh across 16 lots, as filed), executed Jul 15.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 11 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$327.2M

shares × price, as filed

Last traded

Aug 12

Filed Aug 12

Median ADV $130.5M across their filed names

Open performance→

Volume by month

Buys $0 Sells $410.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 11 filings

Sector per market data · by filing · past 12 months

Most traded names

ONC

BeOne Medicines AG ONC · 0 buys · 16 sells 16 filings BGNE BGNE BGNE · 0 buys · 5 sells 5 filings

Recent filings

ONCSALE BeOne Medicines AG View filing → $86.5M
240,739 sh across 22 lots
Exec Aug 10
Filed Aug 12 · 5:53 PM ET ONCSALE BeOne Medicines AG View filing → $34.5M
109,433 sh across 13 lots
Exec Jul 20
Filed Jul 22 · 5:03 PM ET ONCSALE BeOne Medicines AG View filing → $20.1M
64,577 sh across 8 lots
Exec Jul 17
Filed Jul 17 · 5:36 PM ET ONCSALE BeOne Medicines AG View filing → $89.3M
282,921 sh across 16 lots
Exec Jul 15
Filed Jul 17 · 5:31 PM ET ONCSALE BeOne Medicines AG View filing → $44.6M
145,861 sh across 6 lots
Exec Jul 14
Filed Jul 14 · 9:26 PM ET ONCSALE BeOne Medicines AG View filing → $18.1M
59,594 sh across 11 lots
Exec Jul 10
Filed Jul 14 · 9:25 PM ET ONCSALE BeOne Medicines AG View filing → $846K
3,090 sh across 2 lots
Exec Jun 23
Filed Jun 25 · 5:30 PM ET ONCSALE BeOne Medicines AG View filing → $892K
3,360 sh across 2 lots
Exec Jun 16
Filed Jun 18 · 5:30 PM ET More filings →